✦ LIBER ✦

Efficacy and safety of insulin aspart compared to buffered human insulin by continuous SC insulin infusion

✍ Scribed by Bruce Bode; Poul Strange; Kelly McCulloch

Book ID: 117370315
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 139 KB
Volume: 50
Category: Article
ISSN: 0168-8227
DOI: 10.1016/s0168-8227(00)82219-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of Insulin Aspart With Buffer

Comparison of Insulin Aspart With Buffered Regular Insulin and Insulin Lispro in Continuous Subcutaneous Insulin Infusion: A randomized study in type 1 diabetes

✍ Bode, B.; Weinstein, R.; Bell, D.; McGill, J.; Nadeau, D.; Raskin, P.; Davidson, 📂 Article 📅 2002 🏛 American Diabetes Association 🌐 English ⚖ 118 KB

Insulin Glulisine Compared to Insulin As

Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled Trial

✍ van Bon, Arianne C.; Bode, Bruce W.; Sert-Langeron, Caroline; DeVries, J. Hans; 📂 Article 📅 2011 🏛 Mary Ann Liebert 🌐 English ⚖ 253 KB

A comparison of insulin lispro and buffe

A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump

✍ Philip Raskin; John H Holcombe; William V Tamborlane; John I Malone; Suzanne Str 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Efficacy, Safety, and Pump Compatibility

Efficacy, Safety, and Pump Compatibility of Insulin Aspart Used in Continuous Subcutaneous Insulin Infusion Therapy in Patients With Type 1 Diabetes

✍ Bode, B. W.; Strange, P. 📂 Article 📅 2001 🏛 American Diabetes Association 🌐 English ⚖ 66 KB

Efficacy, safety and lack of immunogenic

Efficacy, safety and lack of immunogenicity of insulin aspart compared with regular human insulin for women with gestational diabetes mellitus

✍ D. J. Pettitt; P. Ospina; C. Howard; H. Zisser; L. Jovanovic 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

Continuous subcutaneous insulin infusion

Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness

✍ Régis Pierre Radermecker; André Jacques Scheen 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB